This Advisory is based on TIP 51, Substance Abuse Treatment: Addressing the Specific Needs of Women. It offers guidance to providers and administrators about the particular needs of women during substance use disorder (SUD) treatment.
You May Also Be Interested In
TIP 51: Substance Abuse Treatment: Addressing the Specific Needs of Women
This guide assists providers in offering treatment to women living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of initial use and specific treatment issues and strategies.
Advisory: Screening and Treatment of Substance Use Disorders among Adolescents
This Advisory is based on TIP 31, Screening and Assessing Adolescents for Substance Use Disorders (SUDs) and TIP 32, Treatment of Adolescents with SUDs. It includes recommendations for engaging adolescents in SUD risk assessment, screening, and treatment.
Advisory: Substance Use Disorder Treatment for People with Co-Occurring Disorders
This Advisory is based on TIP 42, Substance Use Disorder Treatment for People with Co-Occurring Disorders. It highlights strategies for counselors and administrators to properly screen, assess, diagnose, and manage the treatment of individuals with co-occurring substance use and mental disorders.
Preventing the Use of Marijuana: Focus on Women and Pregnancy
This guide supports health care providers, systems, and communities seeking to prevent marijuana use by pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Treating Opioid Use Disorder During Pregnancy
This fact sheet (2 of 4) addresses how treatment of pregnant women with opioid use disorder (OUD) can help women have a healthy pregnancy and a healthy baby. This resource describes managing OUD with a treatment plan that includes medicines and counseling.
Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants
This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.